[HTML] springer.comFull View

[HTML][HTML] Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

A Rezapour, Z Behroozi, M Nasirzadeh… - Infectious Diseases of …, 2023 - Springer
Background Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID-19). This study aimed to systematically identify, critically evaluate, and summarize …
被引用次数：4 相关文章

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

A Rezapour, Z Behroozi, M Nasirzadeh… - Infectious Diseases of …, 2023 - europepmc.org
Background Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID-19). This study aimed to systematically identify, critically evaluate, and summarize …

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review.

A Rezapour, Z Behroozi… - … Diseases of Poverty, 2023 - search.ebscohost.com
Background: Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID-19). This study aimed to systematically identify, critically evaluate, and summarize …
[HTML] nih.gov

[HTML][HTML] Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

A Rezapour, Z Behroozi, M Nasirzadeh… - Infectious Diseases of …, 2023 - ncbi.nlm.nih.gov
Background Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID-19). This study aimed to systematically identify, critically evaluate, and summarize …

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

A Rezapour, Z Behroozi… - … diseases of poverty, 2023 - pubmed.ncbi.nlm.nih.gov
Background Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID-19). This study aimed to systematically identify, critically evaluate, and summarize …

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

A Rezapour, Z Behroozi, M Nasirzadeh… - … Diseases of Poverty, 2023 - search.proquest.com
Background Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID-19). This study aimed to systematically identify, critically evaluate, and summarize …

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review.

A Rezapour, Z Behroozi, M Nasirzadeh, M Rezaeian… - 2023 - cabidigitallibrary.org
Background: Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID-19). This study aimed to systematically identify, critically evaluate, and summarize …
[HTML] biomedcentral.com

[HTML][HTML] Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

A Rezapour, Z Behroozi… - Infectious …, 2023 - idpjournal.biomedcentral.com
Remdesivir is being studied and used to treat coronavirus disease 2019 (COVID-19). This
study aimed to systematically identify, critically evaluate, and summarize the findings of the …
[PDF] scienceopen.com

[PDF][PDF] Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

A Rezapour, Z Behroozi, M Nasirzadeh, M Rezaeian… - 2023 - scienceopen.com
Background Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID‑19). This study aimed to systematically identify, critically evaluate, and summarize …
[PDF] biomedcentral.com

[PDF][PDF] Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

A Rezapour, Z Behroozi, M Nasirzadeh, M Rezaeian… - 2023 - idpjournal.biomedcentral.com
Background Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID‑19). This study aimed to systematically identify, critically evaluate, and summarize …